Compare ALK & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALK | TXG |
|---|---|---|
| Founded | 1932 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7B | 5.6B |
| IPO Year | 2003 | 2019 |
| Metric | ALK | TXG |
|---|---|---|
| Price | $46.13 | $46.72 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 15 |
| Target Price | ★ $62.92 | $20.25 |
| AVG Volume (30 Days) | 3.2M | ★ 3.2M |
| Earning Date | 04-20-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 76.97 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,426,000,000.00 | $245,893,000.00 |
| Revenue This Year | $11.19 | N/A |
| Revenue Next Year | $5.11 | $7.33 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 8.09 | ★ 68.06 |
| 52 Week Low | $33.03 | $11.17 |
| 52 Week High | $65.35 | $49.50 |
| Indicator | ALK | TXG |
|---|---|---|
| Relative Strength Index (RSI) | 46.25 | 67.66 |
| Support Level | $36.64 | $16.11 |
| Resistance Level | $47.60 | N/A |
| Average True Range (ATR) | 2.27 | 2.91 |
| MACD | -0.62 | 0.11 |
| Stochastic Oscillator | 43.13 | 81.26 |
Alaska Air Group Inc operates two airlines, Alaska and Horizon, in three operating segments. The Alaska Airlines segment includes scheduled air transportation on Alaska's Boeing and Airbus jet aircraft for passengers and cargo throughout the U.S., and in parts of Mexico and Costa Rica. The Regional segment includes Horizon's and other third-party carriers' scheduled air transportation for passengers across a shorter distance network within the U.S. and Canada under capacity purchase agreements. The Hawaiian Airlines segment includes scheduled air transportation on Hawaiian's Boeing and Airbus aircraft for passengers and cargo. It earns revenues from Passenger tickets, including ticket breakage and net of taxes and fees, Passenger ancillary, and Mileage Plan passenger revenue.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).